PE89199A1 - PHARMACEUTICAL COMPOSITION OF TIAZOLIDINADIONA AND AN ALPHA GLUCOSIDASE INHIBITOR FOR THE TREATMENT OF DIABETES - Google Patents
PHARMACEUTICAL COMPOSITION OF TIAZOLIDINADIONA AND AN ALPHA GLUCOSIDASE INHIBITOR FOR THE TREATMENT OF DIABETESInfo
- Publication number
- PE89199A1 PE89199A1 PE1998000536A PE00053698A PE89199A1 PE 89199 A1 PE89199 A1 PE 89199A1 PE 1998000536 A PE1998000536 A PE 1998000536A PE 00053698 A PE00053698 A PE 00053698A PE 89199 A1 PE89199 A1 PE 89199A1
- Authority
- PE
- Peru
- Prior art keywords
- treatment
- diabetes
- tiazolidinadiona
- pharmaceutical composition
- glucosidase inhibitor
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 3
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 title 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 abstract 1
- -1 AMINO Chemical class 0.000 abstract 1
- 229940122355 Insulin sensitizer Drugs 0.000 abstract 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 abstract 1
- IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 abstract 1
- 229960002632 acarbose Drugs 0.000 abstract 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 abstract 1
- 108010028144 alpha-Glucosidases Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- YZFWTZACSRHJQD-UHFFFAOYSA-N ciglitazone Chemical compound C=1C=C(CC2C(NC(=O)S2)=O)C=CC=1OCC1(C)CCCCC1 YZFWTZACSRHJQD-UHFFFAOYSA-N 0.000 abstract 1
- 229950000269 emiglitate Drugs 0.000 abstract 1
- NWWORXYTJRPSMC-QKPAOTATSA-N ethyl 4-[2-[(2r,3r,4r,5s)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]ethoxy]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1OCCN1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](O)C1 NWWORXYTJRPSMC-QKPAOTATSA-N 0.000 abstract 1
- 229960001110 miglitol Drugs 0.000 abstract 1
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 abstract 1
- GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
CARACTERIZADA PORQUE COMPRENDE a)UN SENSIBILIZADOR A INSULINA TAL COMO 5-[4-[2-(N-METIL-N-(2-PIRIDIL)AMINO)ETOXI]-BENCIL]TIAZOLIDINA-2,4-DIONA UTILIZANDOSE DE 2 mg A 12 mg, O TROGLITAZONA, CIGLITAZONA, PIOGLITAZONA, ENGLITAZONA Y b)UN AGENTE ANTIHIPERGLUCEMICO INHIBIDOR DE ALFA-GLUCOSIDASA TAL COMO ACARBOSA, EMIGLITATO O MIGLITOL. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE LA DIABETES MELLITUS Y PARA LAS CONDICIONES ASOCIADAS A LA DIABETES MELLITUSCHARACTERIZED BECAUSE IT INCLUDES a) AN INSULIN SENSITIZER SUCH AS 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] -BENCIL] THIAZOLIDINE-2,4-DIONA USING 2 mg A 12 mg, OR TROGLITAZONA, CIGLITAZONA, PIOGLITAZONA, ENGLITAZONA AND b) AN ALPHA-GLUCOSIDASE ANTI-HYPERGLUCEMIC AGENT SUCH AS ACARBOSE, EMIGLITATE OR MIGLITOL. THE COMPOSITION MAY BE USEFUL FOR THE TREATMENT OF DIABETES MELLITUS AND FOR THE CONDITIONS ASSOCIATED WITH DIABETES MELLITUS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9712865.6A GB9712865D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
| GBGB9806708.5A GB9806708D0 (en) | 1998-03-27 | 1998-03-27 | Novel method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE89199A1 true PE89199A1 (en) | 1999-10-23 |
Family
ID=26311746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000536A PE89199A1 (en) | 1997-06-18 | 1998-06-18 | PHARMACEUTICAL COMPOSITION OF TIAZOLIDINADIONA AND AN ALPHA GLUCOSIDASE INHIBITOR FOR THE TREATMENT OF DIABETES |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0975343A1 (en) |
| JP (1) | JP2001523271A (en) |
| KR (1) | KR20010013845A (en) |
| CN (1) | CN1274282A (en) |
| AP (1) | AP9901720A0 (en) |
| AR (2) | AR013352A1 (en) |
| AU (1) | AU8799998A (en) |
| BG (1) | BG103966A (en) |
| BR (1) | BR9810186A (en) |
| CA (1) | CA2294134A1 (en) |
| CO (1) | CO4940453A1 (en) |
| DZ (1) | DZ2519A1 (en) |
| EA (1) | EA200000040A1 (en) |
| IL (1) | IL133138A0 (en) |
| MA (1) | MA26510A1 (en) |
| NO (1) | NO996270L (en) |
| NZ (1) | NZ501345A (en) |
| OA (1) | OA11631A (en) |
| PE (1) | PE89199A1 (en) |
| PL (1) | PL337577A1 (en) |
| SK (1) | SK179499A3 (en) |
| TR (1) | TR199903072T2 (en) |
| UY (1) | UY25051A1 (en) |
| WO (1) | WO1998057635A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| BR0009934A (en) | 1999-04-23 | 2002-06-04 | Smithkline Beecham Plc | Pharmaceutical |
| DE60233655D1 (en) | 2001-04-04 | 2009-10-22 | Ortho Mcneil Janssen Pharm | R AND RETINOID X RECEPTOR MODULATORS |
| ES2321815T3 (en) | 2001-04-04 | 2009-06-12 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | THERAPEUTIC COMBINATION THAT INCLUDES REABSORTION AND GLUCOSE INHIBITORS AND PPAR MODULATORS. |
| FR2832930A1 (en) * | 2001-12-03 | 2003-06-06 | Lipha | PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES |
| JP2004067575A (en) * | 2002-08-06 | 2004-03-04 | Yaizu Suisankagaku Industry Co Ltd | Diabetes treatment effect enhancer |
| CN101121004B (en) * | 2006-08-08 | 2010-07-21 | 鲁南制药集团股份有限公司 | Medicine composition containing insulin intensifier and miglitol |
| CN101584688B (en) * | 2008-05-24 | 2010-11-10 | 鲁南制药集团股份有限公司 | Medicament composition for treating diabetes and complications of diabetes |
| CN101584705B (en) * | 2008-05-24 | 2010-10-27 | 鲁南制药集团股份有限公司 | A kind of pharmaceutical composition for treating diabetes and its complications |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0601001B1 (en) * | 1991-08-26 | 1997-04-16 | PHARMACIA & UPJOHN COMPANY | Liquid food product containing 3-guanidinopropionic acid |
| US5917052A (en) * | 1994-09-28 | 1999-06-29 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
| TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
-
1998
- 1998-06-15 WO PCT/EP1998/003691 patent/WO1998057635A1/en not_active Ceased
- 1998-06-15 KR KR1019997011866A patent/KR20010013845A/en not_active Withdrawn
- 1998-06-15 JP JP50375699A patent/JP2001523271A/en not_active Ceased
- 1998-06-15 SK SK1794-99A patent/SK179499A3/en unknown
- 1998-06-15 CN CN98806319A patent/CN1274282A/en active Pending
- 1998-06-15 BR BR9810186-2A patent/BR9810186A/en not_active IP Right Cessation
- 1998-06-15 IL IL13313898A patent/IL133138A0/en unknown
- 1998-06-15 CA CA002294134A patent/CA2294134A1/en not_active Abandoned
- 1998-06-15 AP APAP/P/1999/001720A patent/AP9901720A0/en unknown
- 1998-06-15 EP EP98939513A patent/EP0975343A1/en not_active Withdrawn
- 1998-06-15 PL PL98337577A patent/PL337577A1/en unknown
- 1998-06-15 TR TR1999/03072T patent/TR199903072T2/en unknown
- 1998-06-15 EA EA200000040A patent/EA200000040A1/en unknown
- 1998-06-15 AU AU87999/98A patent/AU8799998A/en not_active Abandoned
- 1998-06-17 DZ DZ980129A patent/DZ2519A1/en active
- 1998-06-17 AR ARP980102882A patent/AR013352A1/en unknown
- 1998-06-17 AR ARP980102885A patent/AR014881A1/en unknown
- 1998-06-17 MA MA25121A patent/MA26510A1/en unknown
- 1998-06-18 PE PE1998000536A patent/PE89199A1/en not_active Application Discontinuation
- 1998-06-18 CO CO98034648A patent/CO4940453A1/en unknown
- 1998-06-18 UY UY25051A patent/UY25051A1/en not_active Application Discontinuation
- 1998-07-15 NZ NZ501345A patent/NZ501345A/en unknown
-
1999
- 1999-12-08 BG BG103966A patent/BG103966A/en unknown
- 1999-12-17 NO NO996270A patent/NO996270L/en not_active Application Discontinuation
- 1999-12-17 OA OA9900295A patent/OA11631A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR014881A1 (en) | 2001-04-11 |
| BR9810186A (en) | 2000-08-08 |
| IL133138A0 (en) | 2001-03-19 |
| DZ2519A1 (en) | 2003-02-01 |
| MA26510A1 (en) | 2004-12-20 |
| UY25051A1 (en) | 2000-09-29 |
| CO4940453A1 (en) | 2000-07-24 |
| CN1274282A (en) | 2000-11-22 |
| AR013352A1 (en) | 2000-12-27 |
| CA2294134A1 (en) | 1998-12-23 |
| WO1998057635A1 (en) | 1998-12-23 |
| NO996270D0 (en) | 1999-12-17 |
| PL337577A1 (en) | 2000-08-28 |
| AP9901720A0 (en) | 1999-12-31 |
| SK179499A3 (en) | 2000-11-07 |
| EP0975343A1 (en) | 2000-02-02 |
| BG103966A (en) | 2000-07-31 |
| NO996270L (en) | 1999-12-17 |
| OA11631A (en) | 2004-11-22 |
| EA200000040A1 (en) | 2000-08-28 |
| TR199903072T2 (en) | 2000-07-21 |
| AU8799998A (en) | 1999-01-04 |
| JP2001523271A (en) | 2001-11-20 |
| KR20010013845A (en) | 2001-02-26 |
| NZ501345A (en) | 2001-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE83199A1 (en) | PHARMACEUTICAL COMPOSITION OF TIAZOLIDINADIONA AND BIGUANIDE FOR THE TREATMENT OF DIABETES | |
| TR200102874T2 (en) | Biphenyl AP2 inhibitors and method with heterocyclic content. | |
| PA8447401A1 (en) | COMBINATIONS FOR SULFONILUREA DIABETES - GLITAZONE | |
| PE99599A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES | |
| AR057970A2 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MELLITUS DIABETES AND CONDITIONS ASSOCIATED WITH MELLITUS DIABETES AND PROCEDURES TO PREPARE SUCH COMPOSITIONS | |
| PE89199A1 (en) | PHARMACEUTICAL COMPOSITION OF TIAZOLIDINADIONA AND AN ALPHA GLUCOSIDASE INHIBITOR FOR THE TREATMENT OF DIABETES | |
| PE104499A1 (en) | PHARMACEUTICAL COMPOSITION OF TIAZOLIDINDIONA AND INSULIN FOR THE TREATMENT OF DIABETES | |
| PE99499A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES | |
| PE99799A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES | |
| PE108199A1 (en) | PHARMACEUTICAL COMPOSITION OF TIAZOLIDINDIONA AND SULFONILUREA | |
| UY26112A1 (en) | 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] THIAZOLIDINE-2,4-DIONA HYDROCHLORIDE | |
| HK1041201A1 (en) | Compatibility of beta agonists and antidiabetic agents | |
| EA200300005A1 (en) | SALT THIAZOLIDINDION FOR THE TREATMENT OF DIABETES MELLITUS | |
| CY1107767T1 (en) | THIAZOLIDINODIONI PRODUCER AND USE OF IT AS ANTIBIOTIC | |
| BR0309375A (en) | Treatment of metabolic syndrome | |
| TR200000957T2 (en) | The use of thiazolidinedione in the treatment of hyperglycemia | |
| ECSP982541A (en) | NEW METHOD OF TREATMENT II | |
| ECSP982592A (en) | NEW METHOD OF TREATMENT V | |
| ECSP982535A (en) | NEW TREATMENT METHOD (I) | |
| ES2174748B1 (en) | NEW SALT OF TIAZOLIDINDIONA AND ITS POLYMORPHES AS ANTI-DIABETIC AGENTS AND PROCEDURE FOR OBTAINING THEMSELVES. | |
| ECSP982534A (en) | NEW METHOD OF TREATMENT | |
| ES2083319B1 (en) | 5- (2- (4- (1,2-BENZISOTIAZOL-3-IL) -1-PIPERAZINYL) -Ethyl) -6-CHLORINE-1,3-DIHYDRO-2H-INDOL-2-ONA MONOHYDRATE. | |
| UY26341A1 (en) | METHOD FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETES. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |